Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional)
National Institutes of Health - Updates to NIH Policy on ESI Application Status
National Institutes of Health - Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-19-147 "Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism - Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-19-146 "Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism - Notice of Special Interest in Supporting Administrative Supplements for Fetal Alcohol Spectrum Disorders (FASD)
National Institute on Alcohol Abuse and Alcoholism - Notice of NIA's Participation in RFA-OD-19-001 "Botanical Dietary Supplements Research Centers (BDSRC) (U19 Clinical Trial Optional)"
National Institute on Aging - Request for Information (RFI): Immunologic Assays for Identifying Correlates of Protection (COP) Against Congenital Cytomegalovirus Transmission and/or Disease
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Special Interest: Administrative Supplements for Characterization and Further Development of Humanized Immune System (HIS) Mice
National Institute of Allergy and Infectious Diseases
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Notice of Expiration of Funding Opportunity Announcements PAR-19-168 and PAR-19-169 "Biology of Bladder Cancer (R01, R21 Clinical Trial Optional)"
National Cancer Institute - Notice: NIDA Accepting Competitive Revision Applications to Establish an Addiction Medicine Practice Based Research Network to Address the National Opioid Crisis
National Institute on Drug Abuse - Notice of Change to Council Dates for PAR-19-143 "NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)"
National Institute on Deafness and Other Communication Disorders - Updates to Section I & II for PAR-15-187 - Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies
Food and Drug Administration - Notice of Change to Funds Available and Award Budget for PAR-16-099 "NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)"
Food and Drug Administration - Notice of Joint SBE/NIGMS Initiative to Support a Science of Science Policy Approach to Analyzing and Innovating the Biomedical Research Enterprise (SCISIPBIO)
National Institute of General Medical Sciences - Request for Information (RFI): Input on In-depth Stem Cell Characterization
National Heart, Lung, and Blood Institute - Notice of NIMHD Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)"
National Institute on Minority Health and Health Disparities - Notice to Extend PAR-19-027, "Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed)"
National Institute of Mental Health - Notice to Extend, PAR-19-028 "Basic Neurodevelopmental Biology of Brain Circuits and Behavior (R21 Clinical Trial Not Allowed)
National Institute of Mental Health - Notice of Correction for RFA-MH-18-700 "Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (Collaborative R01 Clinical Trial Required)"
National Institute of Mental Health - Notice of Correction for RFA-MH-18-701 "Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (R01 Clinical Trial Required)"
National Institute of Mental Health - Notice of Correction for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)"
National Institute of Mental Health - Notice of Correction for RFA-MH-18-704 "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required)"
National Institute of Mental Health - Notice of Correction for RFA-MH-18-705, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)"
National Institute of Mental Health - Notice of Correction for RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)"
National Institute of Mental Health - Notice of Correction for RFA-MH-18-707, "Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)"
National Institute of Mental Health - Notice of Removal of Matching Requirement Instructions for RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)".
National Institute of Neurological Disorders and Stroke - Notice of Removal of Matching Requirement Instructions for RFA-NS-19-017 "HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)".
National Institute of Neurological Disorders and Stroke - Notice of Removal of Matching Requirement Instructions for RFA-NS-19-018 "HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)".
National Institute of Neurological Disorders and Stroke - Notice of Correction to Cooperative Agreement Terms and Conditions of Award for RFA-NS-19-020 "HEAL Initiative: Optimization of Non-addictive Therapies (Small Molecules and Biologics) to Treat Pain (U44 - Clinical Trial Not Allowed)".
National Institute of Neurological Disorders and Stroke - Notice of Change to IC and NIH Office of Interest Areas and Specific Requirements for RFA-NS-19-009 "Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Requests for Applications
- Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed)
Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)
Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed)
Food and Drug Administration
- Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required)
Food and Drug Administration
- Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed)
Food and Drug Administration
- Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required)
Food and Drug Administration
- Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required)
National Institute of Mental Health
- Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
Office of Research on Women's Health
. - Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
Program Announcements
- Biology of Bladder Cancer (R01 Clinical Trial Optional)
- Biology of Bladder Cancer (R21 Clinical Trial Optional)
National Cancer Institute
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu